BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang X, Wang W, Ma X, Lu X, Li S, Zeng M, Xu K, Yang C. Combined hepatocellular-cholangiocarcinoma: which preoperative clinical data and conventional MRI characteristics have value for the prediction of microvascular invasion and clinical significance? Eur Radiol 2020;30:5337-47. [PMID: 32385649 DOI: 10.1007/s00330-020-06861-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Xiao Y, Zheng X, Zhou C, Huang P, Wu F, Yang C, Zeng M. Combined hepatocellular carcinoma-cholangiocarcinoma with a predominant HCC component: better survival and MRI-based prediction. Eur Radiol. [DOI: 10.1007/s00330-022-09131-5] [Reference Citation Analysis]
2 Zhou C, Lu X, Wang Y, Qian X, Yang C, Zeng M. Histopathological components correlated with MRI features and prognosis in combined hepatocellular carcinoma-cholangiocarcinoma. Eur Radiol 2022. [PMID: 35976399 DOI: 10.1007/s00330-022-09065-y] [Reference Citation Analysis]
3 Liu X, Ni X, Li Y, Yang C, Wang Y, Ma C, Zhou C, Lu X. Diagnostic Performance of LI-RADS Version 2018 for Primary Liver Cancer in Patients With Liver Cirrhosis on Enhanced MRI. Front Oncol 2022;12:934045. [DOI: 10.3389/fonc.2022.934045] [Reference Citation Analysis]
4 Chen Y, Lu Q, Zhu Y, Huang B, Dong Y, Wang W. Prediction of Microvascular Invasion in Combined Hepatocellular-Cholangiocarcinoma Based on Pre-operative Clinical Data and Contrast-Enhanced Ultrasound Characteristics. Ultrasound Med Biol 2022;48:1190-201. [PMID: 35397928 DOI: 10.1016/j.ultrasmedbio.2022.02.014] [Reference Citation Analysis]
5 Li S, Shen C, Ding Z, She H, Du YP. Accelerating multi-echo chemical shift encoded water-fat MRI using model-guided deep learning. Magn Reson Med 2022. [PMID: 35649172 DOI: 10.1002/mrm.29307] [Reference Citation Analysis]
6 Wang Y, Zhu GQ, Zhou CW, Li N, Yang C, Zeng MS. Risk stratification of LI-RADS M and LI-RADS 4/5 combined hepatocellular cholangiocarcinoma: prognostic values of MR imaging features and clinicopathological factors. Eur Radiol 2022. [PMID: 35316365 DOI: 10.1007/s00330-022-08691-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Sheng R, Huang X, Jin K, Gao S, Zeng M, Wu D, Shi G. Contrast-enhanced MRI could predict response of systemic therapy in advanced intrahepatic cholangiocarcinoma. Eur Radiol 2022. [PMID: 35298678 DOI: 10.1007/s00330-022-08679-6] [Reference Citation Analysis]
8 Wu Y, Liu H, Zeng J, Chen Y, Fang G, Zhang J, Zhou W, Zeng Y, Liu J. Development and validation of nomogram to predict very early recurrence of combined hepatocellular-cholangiocarcinoma after hepatic resection: a multi-institutional study. World J Surg Onc 2022;20. [DOI: 10.1186/s12957-022-02536-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Yang Y, Zou X, Zhou W, Yuan G, Hu D, Kuang D, Shen Y, Xie Q, Zhang Q, Hu X, Li Z. Multiparametric MRI-Based Radiomic Signature for Preoperative Evaluation of Overall Survival in Intrahepatic Cholangiocarcinoma After Partial Hepatectomy. J Magn Reson Imaging 2022. [PMID: 35049076 DOI: 10.1002/jmri.28071] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Wang Y, Zhou CW, Zhu GQ, Li N, Qian XL, Chong HH, Yang C, Zeng MS. A multidimensional nomogram combining imaging features and clinical factors to predict the invasiveness and metastasis of combined hepatocellular cholangiocarcinoma. Ann Transl Med 2021;9:1518. [PMID: 34790724 DOI: 10.21037/atm-21-2500] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Zhou C, Ni X, Lu X, Wang Y, Qian X, Yang C, Zeng M. MR Features Based on LI-RADS Ver. 2018 Correlated with Cytokeratin 19 Expression in Combined Hepatocellular Carcinoma-Cholangiocarcinoma. J Hepatocell Carcinoma 2021;8:975-83. [PMID: 34458204 DOI: 10.2147/JHC.S325686] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
12 Zhou C, Wang Y, Ma L, Qian X, Yang C, Zeng M. Combined hepatocellular carcinoma-cholangiocarcinoma: MRI features correlated with tumor biomarkers and prognosis. Eur Radiol 2021. [PMID: 34279688 DOI: 10.1007/s00330-021-08188-y] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
13 Wang J, Li Z, Liao Y, Li J, Dong H, Peng H, Xu W, Fan Z, Gao F, Liu C, Liu D, Zhang Y. Prediction of Survival and Analysis of Prognostic Factors for Patients With Combined Hepatocellular Carcinoma and Cholangiocarcinoma: A Population-Based Study. Front Oncol 2021;11:686972. [PMID: 34336671 DOI: 10.3389/fonc.2021.686972] [Reference Citation Analysis]
14 Chong H, Zhou P, Yang C, Zeng M. An excellent nomogram predicts microvascular invasion that cannot independently stratify outcomes of small hepatocellular carcinoma. Ann Transl Med 2021;9:757. [PMID: 34268370 DOI: 10.21037/atm-20-7952] [Cited by in F6Publishing: 3] [Reference Citation Analysis]